Delivery Order SPE2DB22D3501-SPE2DB25FUG04
Award Date
1/22/25
Potential Completion Date
1/23/25
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,819.58 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a prescription medication. The contract has an ultimate completion date of September 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,551.60, is a delivery order for OVIDREL 250 MCG/0.5 ML SYRG 0.5ML medical supplies. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,242.80, is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The $4,201.80 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a performance period ending on July 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,734.40 firm fixed-price delivery order contract covers the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty medication, to support military healthcare programs. The award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,731.79, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $1,789.07 firm fixed price delivery order is for 4563830856, described as OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, to be delivered by March 4, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,414.58, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract has a ceiling value of $3,585.48 and is a firm fixed-price delivery order. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,723.76 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 15, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...